share_log

RBC Capital Downgrades Applied Therapeutics to Sector Perform, Lowers Price Target to $4

RBC Capital Downgrades Applied Therapeutics to Sector Perform, Lowers Price Target to $4

RBC资本将应用治疗学评级下调至板块表现,目标价格下调至4美元
Benzinga ·  11/29 23:18  · 评级/大行评级

RBC Capital analyst Brian Abrahams downgrades Applied Therapeutics (NASDAQ:APLT) from Outperform to Sector Perform and lowers the price target from $12 to $4.

RBC Capital 分析师布赖恩·阿布拉哈姆斯将应用治疗(applied therapeutics)的评级从跑赢大盘下调至板块表现,并将价格目标从12美元下调至4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发